Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CDNAthis companyCareDx, Inc	$84.90	-47.1×	3.31×	2.64×	-207.24×	-113.5%	67.6%	-6.6%	-5.6%	-7.0%	-7.6%	3.6%	0.09×	8.43×	0×	2.86×	0.0%	6	15.65	3	B+
BLLNBillionToOne, Inc.	$113.55	1,284.77×	7.81×	12.29×	170.11×	1225.6%	68.3%	5.3%	2.4%	1.6%	2.6%	0.4%	0.23×	-19.59×	168.66×	11.69×	0.0%	7	17.31	3	B-
FLGTFulgent Genetics, Inc.	$24.25	-13.34×	0.73×	2.51×	-16.71×	-77.3%	40.6%	-28.2%	-18.8%	-5.4%	-7.1%	-15.4%	0.01×	0.93×	-1,214.61×	6.48×	0.0%	5	4.47	3	B-
MYGNMyriad Genetics, Inc.	$5.77	-1.55×	1.56×	0.7×	-1.92×	-408.9%	69.9%	-8.2%	-44.4%	-99.4%	-10.8%	-4.5%	0.57×	-0.18×	-6.46×	2.49×	0.0%	4	-0.56	1	C-
NTRANatera, Inc.	$321.88	-150.72×	18.29×	13.58×	-138.12×	-182.4%	64.8%	-13.4%	-9.0%	-12.2%	-11.1%	0.3%	0.13×	3.91×	-76.16×	3.39×	0.0%	3	42.53	1	C-
VCYTVeracyte, Inc.	$25.91	50.12×	2.53×	6.4×	33.31×	-24.0%	69.6%	14.3%	12.8%	5.1%	5.3%	3.8%	0.03×	-3.6×	0×	8.15×	0.0%	7	24.96	3	B+
Peer median	—	-1.55×	2.53×	6.4×	-1.92×	-77.3%	68.3%	-8.2%	-9.0%	-5.4%	-7.1%	0.3%	0.13×	-0.18×	-6.46×	6.48×	0.0%	5	17.31	3	—